期刊： JOURNAL OF PSYCHOPHARMACOLOGY, 2023; 37 (9)
Background: Bipolar disorder (BD) and cannabis use are each associated with neurocognitive deficits in adolescents. However, little is known regarding......
期刊： JOURNAL OF PSYCHOPHARMACOLOGY, 2023; 37 (10)
Background: Clozapine is the most effective antipsychotic but requires careful titration to therapeutic blood levels. Methods to predict therapeutic d......
期刊： JOURNAL OF PSYCHOPHARMACOLOGY, 2023; 37 (11)
Background: In clinical studies, psychedelics including psilocybin and D-lysergic acid diethylamide (LSD) demonstrate rapid and persistent antidepress......
期刊： JOURNAL OF PSYCHOPHARMACOLOGY, 2023; 37 (2)
Background: Withdrawal from addictive drugs can be reduced by administering placebo deceptively, but in the clinic it is unethical to deceive the pati......
期刊： JOURNAL OF PSYCHOPHARMACOLOGY, 2023; 37 (8)
Background: Hippocampal phase precession, which depends on the precise spike timing of place cells relative to local theta oscillations, has been prop......
期刊： JOURNAL OF PSYCHOPHARMACOLOGY, 2023; 37 (10)
Background: Preliminary evidence suggest clozapine is associated with more favorable impact on concurrent substance use disorder related outcomes in p......
期刊： JOURNAL OF PSYCHOPHARMACOLOGY, 2023; 37 (6)
Background: Current Diagnostic and Statistical Manual of Mental Disorders (DSM)-5-based research provides limited data on the use of risperidone on ch......
期刊： JOURNAL OF PSYCHOPHARMACOLOGY, 2023; 37 (1)
Background: Clinical use of psychedelics has gained considerable attention, with promising benefits across a range of mental disorders. Current pharma......
期刊： JOURNAL OF PSYCHOPHARMACOLOGY, 2023; 37 (7)
Background: Despite the growth of psychedelic research, psychedelic-assisted group psychotherapy (PAGP) has received little attention in comparison to......
